Kamada KMDA
NASDAQ KMDA
$8.05 +0.16 (+2.03%)
At close: Aug 20, 2026 · 12:50 PM UTC

Kamada (KMDA) Other Non-Current Liabilities (2021 - 2026)

Kamada's (KMDA) quarterly Other Non-Current Liabilities came in at $29.9 million in Q1 2026, down 9.29% YoY from $33.0 million in Q1 2025, and down 0.62% on a QoQ basis from $30.1 million in Q4 2025.

Kamada (KMDA) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Kamada (KMDA) has 6 years of Other Non-Current Liabilities data on file, last reported at $29.9 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 9.29% year-over-year to $29.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.9 million (down 9.29% YoY) and the FY2025 annual result came in at $30.1 million, down 8.24% from the prior year.
  • Other Non-Current Liabilities retreated to $29.9 million in Q1 2026, from $30.1 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $42.5 million in Q1 2022 to a low of $37280.0 in Q1 2023.
  • A 5-year average of $30.8 million and a median of $34.1 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Other Non-Current Liabilities slumped 99.91% — and 2024, when it soared 93360.3%.
  • Tracing KMDA's Other Non-Current Liabilities over 5 years: stood at $37.3 million in 2022, then declined by 7.85% to $34.4 million in 2023, then fell by 4.55% to $32.8 million in 2024, then declined by 8.24% to $30.1 million in 2025, then slipped by 0.62% to $29.9 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $29.9 million (Q1 2026), $30.1 million (Q4 2025), and $32.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn
3 Zoetis 31.79 Bn 30.11 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.69 Bn 22.89 Bn 5.10 Bn
5 United Therapeutics 22.25 Bn 19.58 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Kamada 463.48 Mn 434.00 Mn 22.47 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 28.96 Mn
Mar 31, 2026 29.93 Mn
Dec 31, 2025 30.11 Mn
Sep 30, 2025 32.54 Mn
Jun 30, 2025 32.78 Mn
Mar 31, 2025 32.99 Mn
Dec 31, 2024 32.82 Mn
Sep 30, 2024 34.12 Mn
Jun 30, 2024 34.24 Mn
Mar 31, 2024 34.84 Mn
Dec 31, 2023 34.38 Mn
Sep 30, 2023 36.48 Mn
Jun 30, 2023 36.51 Mn
Mar 31, 2023 37,280.00
Dec 31, 2022 37.31 Mn
Sep 30, 2022 39,915.00
Jun 30, 2022 41.30 Mn
Mar 31, 2022 42.53 Mn
Dec 31, 2021 43.93 Mn